FCEM-0100

A study investigating the risk of suffering a stroke in patients with atrial fibrillation taking the new antiplatelet drug ticagrelor, compared with standard treatment with warfarin is done over a 2-year time period. 30 of the 300 patients taking ticagrelor and 20 of the 500 patients taking warfarin suffered a stroke over the 2-year period.

One of these statements is true regarding the outcomes of this study.